Ecolab heads into its third-quarter report with a clear narrative and a fresh complication. Last quarter, management shifted from describing a transition year to describing momentum across the portfolio. Organic growth reached 5%, pricing rebounded, and the high-tech ambitions grew larger. This is also the first full quarter with CoolIT inside the numbers. That means the reported figures will mix a strong top line with an acquisition that dilutes earnings in the near term. The question is whether the underlying engine keeps accelerating while the deal accounting does its damage.
Wall Street expects earnings of $2.18 per share on revenue of about $4.67 billion. That would mean revenue growth of roughly 12% from a year ago but EPS growth of only about 5%. The gap is the story in miniature. Revenue gets a lift from CoolIT and the earlier Avivo deal. Earnings carry roughly $0.20 per quarter of CoolIT amortization and financing costs. The consensus sits exactly at the midpoint of management's $2.13 to $2.23 guidance. The Earnings Whisper of $2.20 is only modestly higher, so the bar is a clean, ordinary beat rather than a blowout. For the full year, the Street's $8.18 estimate sits in the upper half of the slightly raised $8.05 to $8.25 range. That leaves little room for a soft fourth-quarter outlook.
Pricing is the most important operating check. Management guided second-half pricing to 5% to 6% as the energy surcharge fully takes hold, up from 4% in the second quarter. Evidence that pricing reached that range would validate the margin plan. Management has guided to a second-half adjusted operating margin of about 19%, which keeps the 20% target for 2027 intact. A shortfall would matter more than usual. High single-digit commodity inflation persists through year-end, and Avivo's geographic mix still costs about 60 basis points of gross margin. If pricing slips, those headwinds could take over the margin story.
Volume is the softer flank. It held at just 1% last quarter, with about a point lost to customer disruption from the Middle East conflict, and Institutional is contending with restaurant traffic down around 5%. A rebound toward the 2% underlying pace seen late last year would show that the second-quarter weakness was temporary, as management suggested. Flat or slipping volume would raise a harder question: whether Ecolab's growth is increasingly a pricing story rather than a demand story.
The growth engines need to keep running hot. Life sciences accelerated to 15%, global high-tech grew 29%, Ecolab Digital reached 27%, and food and beverage improved to 7%. Paper finally turned positive. Management has already warned that life sciences margins will drop to the high teens this quarter on reinvestment, so a decline there should not alarm anyone. Revenue growth there, however, needs to hold up, helped by the new China purification plant easing capacity limits. Any early detail on CoolIT's growth trajectory will also carry weight. The November 17 investor day at SuperCompute is likely to center on the integrated cooling platform and the raised 2030 high-tech target of $4 billion in sales.
Sentiment has cooled slightly, moving from mildly bearish to a bit more bearish than before the last report. Meanwhile, the stock has edged ahead of the S&P 500 since then. At about $289, the stock trades comfortably above its 200-day moving average. It sits within roughly 2.5% of its post-earnings high near $296, which puts a breakout within reach if results cooperate. In short, the market has given Ecolab credit without getting carried away.
What ultimately matters is whether pricing reaches the promised 5% to 6% and holds the 19% margin target while CoolIT dilutes earnings. If that happens alongside even modest volume improvement, last quarter's improving narrative stays intact heading into the investor day. If pricing or volume disappoints, the dilution becomes much harder to look past.